Modulation of ovarian function by an oral contraceptive containing 30 mu g ethinyl estradiol in combination with 2.00 mg dienogest

被引:26
作者
Spona, J
Feichtinger, W
Kindermann, C
Moore, C
Mellinger, U
Walter, F
Graser, T
机构
[1] UNIV VIENNA,DEPT OBSTET & GYNECOL,DIV MOL ENDOCRINOL,VIENNA,AUSTRIA
[2] UNIV VIENNA,LUDWIG BOLTZMANN INST EXPT ENDOCRINOL,DIV CELLULAR ENDOCRINOL,VIENNA,AUSTRIA
[3] INST STERIL TREATMENT,VIENNA,AUSTRIA
[4] JENAPHARM GMBH & CO KG,CLIN RES,JENA,GERMANY
关键词
oral contraceptives; dienogest; follicle growth;
D O I
10.1016/S0010-7824(97)00123-6
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Twenty-two healthy female volunteers with normal ovulatory cycles, aged between 20 and 34 years (27.3 +/- 4.1), were included in a single-center, noncomparative study to investigate the modulation of ovarian function by an oral contraceptive containing 30 mu g ethinyl estradiol in combination with 2.00 mg dienogest. At baseline, during three treatment cycles and post-treatment, serum levels of luteinizing hormone, follicle-stimulating hormone, 17 beta-estradiol, and progesterone were assayed and ultrasonography was used to measure follicular size and the thickness of the endometrium. The primary efficacy variable was inhibition of ovulation as measured by ovarian activity grading. All volunteers ovulated during the pretreatment cycle. During treatment, none of the subjects had ovulatory cycles, although there was still some ovarian activity in several subjects. During the first treatment cycle, only 4% (1 subject) of cycles showed active follicle-like structures. The frequency of follicle-like structures increased to 33% and 35% during treatment cycles 2 and 3. The frequency of presumptive luteinized unruptured follicle-like structures was 5% (1 subject) and 15% (3 subjects) in treatment cycles 2 and 3. The serum hormone concentrations were effectively suppressed in comparison to baseline. The ovarian activity returned to baseline during the post-treatment period. One subject was excluded from further study because of a medical problem believed unrelated to use of the oral contraceptive. No serious adverse events were recorded during the course of the study. The results of the present investigation indicate that the modulatory effects on ovarian function of the monophasic oral contraceptive containing 30 mu g ethinyl estradiol combined with 2.00 mg dienogest lead to adequate suppression of ovarian activity and effective inhibition of ovulation. (C) 1997 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 22 条
[1]  
Bonnar J, 1987, Int J Fertil, V32 Suppl, P21
[2]   COAGULATION EFFECTS OF ORAL CONTRACEPTION [J].
BONNAR, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 157 (04) :1042-1048
[3]  
*COMM SAF DRUGS, 1970, BRIT MED J, V1, P231
[4]   COMPARATIVE-STUDIES OF 30-MU-G ETHINYL ESTRADIOL COMBINED WITH GESTODENE AND DESOGESTREL ON BLOOD-COAGULATION, FIBRINOLYSIS, AND PLATELETS [J].
DALY, L ;
BONNAR, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (01) :430-437
[5]   PATTERNS OF CONTRACEPTIVE PILL TAKING IN AN INNER-CITY PRACTICE [J].
FINLAY, IG ;
SCOTT, MGB .
BRITISH MEDICAL JOURNAL, 1986, 293 (6547) :601-602
[6]   A COMPARISON OF THE EFFECTS OF 2 MONOPHASIC LOW-DOSE ORAL-CONTRACEPTIVES ON THE INHIBITION OF OVULATION [J].
FITZGERALD, C ;
FEICHTINGER, W ;
SPONA, J ;
ELSTEIN, M ;
LUDICKE, F ;
MULLER, U ;
WILLIAMS, C .
ADVANCES IN CONTRACEPTION, 1994, 10 (01) :5-18
[7]   LONGITUDINAL ULTRASONOGRAPHIC STUDY OF THE OVARIAN SUPPRESSIVE ACTIVITY OF A LOW-DOSE TRIPHASIC ORAL-CONTRACEPTIVE DURING CORRECT AND INCORRECT PILL INTAKE [J].
HAMILTON, CJCM ;
HOOGLAND, HJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 161 (05) :1159-1162
[8]  
JEFFCOATE TNA, 1970, BRIT MED J, V1, P293
[9]  
KILLICK S R, 1990, Advances in Contraception, V6, P33, DOI 10.1007/BF01849485
[10]  
KILLICK SR, 1989, FERTIL STERIL, V52, P80